medigraphic.com
Instituto Nacional de Salud Pública

2022, Number 1

<< Back Next >>

salud publica mex 2022; 64 (1)

Liver cancer mortality in Mexico: trend analysis from 1998 to 2018

Álvarez CS, Espinosa-Tamez P, López-Ridaura R, Lamadrid-Figueroa H, Melchor-Ruan J, McGlynn KA, Lajous M

Language: English
References: 31
Page: 14-25
PDF size: 569.46 Kb.


ABSTRACT

Objective. To examine overall, sex, and state-specific liver cancer mortality trends in Mexico. Materials and methods. Joinpoint regression was used to examine the trends in age-standardized mortality rates of liver cancer between 1998-2018. Estimated annual percent change with 95% confidence intervals (95%CI) were computed. Age-period-cohort models were used to assess the effects of age, calendar year, and birth cohort. Results. The state-specific mortality rates ranged from 3.34 (Aguascalientes) to 7.96 (Chiapas) per 100 000 person-years. Sex-specific rates were roughly equal, nationwide. Overall, we observed a statistically significant decrease in liver cancer mortality rates between 1998-2018 (annual percent change, -0.8%; 95%CI -1.0, -0.6). The overall age-period-cohort models suggest that birth cohort may be the most important factor driving the trends. Conclusions. While there was overall decline in liver cancer mortality, differences in rates by region were observed. The regional differences may inform future studies of liver cancer etiology across the country.


REFERENCES

  1. McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of Hepatocellular Carcinoma. Hepatology. 2021;73(supl 1):4-13. https://doi.org/10.1002/ hep.31288

  2. Ferlay J, Ervik M, Colombet M, Piñeros M, Znaor A, Soerjomataram I, et al. Global Cancer Observatory: Cancer Today [internet]. Lyon: International Agency for Research on Cancer, 2020. Available from: https://gco. iarc.fr/today

  3. Petrick JL, Florio AA, Znaor A, Ruggieri D, Laversanne M, Alvarez CS, et al. International trends in hepatocellular carcinoma incidence, 1978-2012. Int J Cancer. 2020;147(2):317-30. https://doi.org/10.1002/ijc.32723

  4. Wong MC, Jiang JY, Goggins WB, Liang M, Fang Y, Fung FD, et al. International incidence and mortality trends of liver cancer: a global profile. Sci Rep. 2017;7:45846. https://doi.org/10.1038/srep45846

  5. Wallace MC, Preen D, Jeffrey GP, Adams LA. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroenterol Hepatol. 2015;9(6):765-79. https://doi.org/10.1586/17474124.2015.1028363

  6. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118-27. https://doi.org/10.1056/NEJMra1001683

  7. Polaris Observatory C. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383-403. https://doi.org/10.1016/S2468- 1253(18)30056-6

  8. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22(34):7824-40. https://doi.org/10.3748/wjg.v22.i34.7824

  9. Barquera S, Rivera JA. Obesity in Mexico: rapid epidemiological transition and food industry interference in health policies. Lancet Diabetes Endocrinol. 2020;8(9):746-7. https://doi.org/10.1016/S2213-8587(20)30269-2

  10. Institute for Health Metrics and Evaluation. GBD Compare Data Visualization [internet]. Seattle: IHME, University of Washington, 2020. Available from: http://vizhub.healthdata.org/gbd-compare

  11. Mendez-Sanchez N, Garcia-Villegas E, Merino-Zeferino B, Ochoa-Cruz S, Villa AR, Madrigal H, et al. Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal states. Ann Hepatol. 2010;9(4):428-38.

  12. Torres-Poveda K, Burguete-Garcia AI, Madrid-Marina V. Liver cirrhosis and hepatocellular carcinoma in Mexico: impact of chronic infection by hepatitis viruses B and C. Ann Hepatol. 2011;10(4):556-8.

  13. Mendez-Sanchez N, Villa AR, Vazquez-Elizondo G, Ponciano-Rodriguez G, Uribe M. Mortality trends for liver cancer in Mexico from 2000 to 2006. Ann Hepatol. 2008;7(3):226-9.

  14. Consejo Nacional de Población. Datos Abiertos de México - Proyecciones de la Población de México y de las Entidades Federativas, 2016-2050 [internet]. Ciudad de México: Conapo, 2020. Available from: https://datos. gob.mx/busca/dataset/proyecciones-de-la-poblacion-de-mexico-y-de-lasentidades- federativas-2016-2050

  15. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: A new WHO standard. Geneva: World Health Organization, 2001.

  16. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335- 51. https://doi.org/10.1002/(sici)1097-0258(20000215)19:3<335::aidsim336> 3.0.co;2-z

  17. Holford TR, Zhang Z, McKay LA. Estimating age, period and cohort effects using the multistage model for cancer. Stat Med. 1994;13(1):23-41. https://doi.org/10.1002/sim.4780130105

  18. Lin L, Yan L, Liu Y, Qu C, Ni J, Li H. The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017. Liver Cancer. 2020;9(5):563-82. https://doi. org/10.1159/000508568

  19. Yeverino-Gutierrez ML, Gonzalez-Gonzalez MDR, Gonzalez-Santiago O. Mortality From Alcohol-Related Liver Cirrhosis in Mexico (2000- 2017). Front Public Health. 2020;8:524356. https://doi.org/10.3389/ fpubh.2020.524356

  20. Salvatore M, Jeon J, Meza R. Changing trends in liver cancer incidence by race/ethnicity and sex in the US: 1992-2016. Cancer Causes Control. 2019;30(12):1377-88. https://doi.org/10.1007/s10552-019-01237-4

  21. Escobar ER, Gamino MNB, Salazar RM, Hernandez ISS, Martinez VC, Bautista CF, et al. National trends in alcohol consumption in Mexico: results of the National Survey on Drug, Alcohol and Tobacco Consumption 2016-2017. Salud Ment. 2018;41(1):7-15. https://doi.org/10.17711/ Sm.0185-3325.2018.003

  22. Camarillo EH, Ramirez-Martinez A, Carvajal-Moreno M, Vargas-Ortiz M, Wesolek N, Rodriguez Jimenes GDC, et al. Assessment of Aflatoxin M1 and M2 exposure risk through Oaxaca cheese consumption in southeastern Mexico. Int J Environ Health Res. 2018;28(2):202-13. https://doi.org/10 .1080/09603123.2018.1453054

  23. Castillo-Urueta P, Carvajal M, Mendez I, Meza F, Galvez A. Survey of aflatoxins in maize tortillas from Mexico City. Food Addit Contam Part B Surveill. 2011;4(1):42-51. https://doi.org/10.1080/19393210.20 10.533390

  24. Suarez-Bonnet E, Carvajal M, Mendez-Ramirez I, Castillo-Urueta P, Cortes-Eslava J, Gomez-Arroyo S, et al. Aflatoxin (B1, B2, G1 and G2) contamination in rice of Mexico and Spain, from local sources or imported. J Food Sci. 2013;78(11):T1822-9. https://doi.org/10.1111/1750- 3841.12291

  25. Smith JW, Kroker-Lobos MF, Lazo M, Rivera-Andrade A, Egner PA, Wedemeyer H, et al. Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence. PLoS One. 2017;12(12):e0189255. https://doi. org/10.1371/journal.pone.0189255

  26. Kensler TW, Roebuck BD, Wogan GN, Groopman JD. Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol Sci. 2011;120(supl 1):S28-48. https://doi.org/10.1093/toxsci/kfq283

  27. Agosti P, Sabba C, Mazzocca A. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment. Biochim Biophys Acta Mol Basis Dis. 2018;1864(2):607-17. https:// doi.org/10.1016/j.bbadis.2017.11.026

  28. Pinto Marques Souza de Oliveira C, Pinchemel Cotrim H, Arrese M. Nonalcoholic Fatty Liver Disease Risk Factors in Latin American Populations: Current Scenario and Perspectives. Clin Liver Dis (Hoboken). 2019;13(2):39-42. https://doi.org/10.1002/cld.759

  29. Meza R, Barrientos-Gutierrez T, Rojas-Martinez R, Reynoso-Noveron N, Palacio-Mejia LS, Lazcano-Ponce E, et al. Burden of type 2 diabetes in Mexico: past, current and future prevalence and incidence rates. Prev Med. 2015;81:445-50. https://doi.org/10.1016/j.ypmed.2015.10.015

  30. Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83(3):171-7.

  31. Lozano-Esparza S, Stern D, Hernandez-Avila JE, Morales-Carmona E, Mohar A, Lajous M. Evaluation of Mexico’s low cancer mortality using two national death registries. Salud Publica Mex. 2020;62(2):181-5. https://doi. org/10.21149/10635




2020     |     www.medigraphic.com